Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) United States of America (USA)
Research
Date range: 1 December 2022 - 30 November 2023
Research collaboration: Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Relationships
Partner Institutions
Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Fred Hutchinson Cancer Research Center (FHCRC)
- Genetic Associations and Mechanisms in Oncology (GAME-ON)
- German Cancer Research Center in the Helmholtz Association (DKFZ)
- Harvard University
- NIH National Cancer Institute (NCI)
- Queen Mary University of London (QMUL)
- Stanford University
- The University of Chicago (UChicago)
- The University of Utah (Utah)
- University of Cambridge
- University of Southern California (USC)
- Vanderbilt University (VU)